The Lp(a) lipoprotein represents a quantitative genetic trait. It contains two different polypeptide chains, the Lp(a) glycoprotein and apo B-100. We have demonstrated the Lp(a) glycoprotein directly in human sera by sodium dodecyl sulfate-gel electrophoresis under reducing conditions after immunoblotting using anti-Lp(a) serum and have observed inter-and intraindividual size heterogeneity of the glycoprotein with apparent molecular weights ranging from 400,000-700,000 D. According to their relative mobilities compared with apo B-100 Lp(a) patterns were categorized into phenotypes F (faster than apo B-100), B (similar to apo B-100), Si, S2, S3, and S4 (all slower than apo B-100), and into the respective double-band phenotypes. Results from neuraminidase treatment of isolated Lp(a) glycoprotein indicate that the phenotypic differences do not reside in the sialic acid moiety of the glycoprotein. Family studies are compatible with the concept that Lp(a) glycoprotein phenotypes are controlled by a series of autosomal alleles (LplaIF, LplajB, Lplar', Lplar2, Lplae, Lpla'4, and Lplar) at a single locus. Comparison of Lp(a) plasma concentrations in different phenotypes revealed a highly significant association of phenotype with concentration.
Introduction
The Lp(a) lipoprotein was first demonstrated in human plasma by Berg (1) as a genetic variant oflow-density lipoprotein (LDL)' and believed to be transmitted as an autosomal dominant trait (1) . Later investigators using quantitative immunochemical methods have provided evidence that the Lp(a) lipoprotein represents a quantitative rather than a qualitative genetic marker and is under polygenic control probably with a major gene effect for high Lp(a) concentrations (2) (3) (4) . As (6) (7) (8) . Therefore it has been postulated that high concentrations of the Lp(a) lipoprotein in plasma represent an independent risk factor for the development of coronary heart disease (8) .
The Lp(a) lipoprotein is a spherical particle of250 A diameter that floats in a density range of 1.05 to 1.1 g/ml. The lipid composition ofLp(a) lipoprotein closely resembles that ofLDL. The protein moiety consists primarily of apo B-l00 and the Lp(a) protein (9) (10) (11) (12) (13) . The Lp(a) protein is a glycoprotein rich in neuraminic acid that stains strongly with periodic acid-Schiff and exhibits a high apparent molecular weight upon sodium dodecyl sulfate-gel electrophoresis (SDS-PAGE) (10, 12, 13) . It is linked to apo B-I00 by one or more disulfide bridges in the intact particle (12, 13). It is not known whether the Lp(a) glycoprotein interacts with lipids and is a true apolipoprotein. The presence of apo B-100 in the Lp(a) lipoprotein explains its immunochemical cross-reactivity with LDL whereas the Lp(a) protein is responsible for the specific immunochemical properties and the higher density of the Lp(a) lipoprotein. There are conflicting results on the binding of Lp(a) lipoprotein to the LDL (B/E) receptor (14) (15) (16) (17) .
Recent studies on isolated Lp(a) lipoprotein have demonstrated density heterogeneity ofthe lipoprotein (18, 19) and size heterogeneity of the Lp(a) glycoprotein ( 13, 19) . In the present study we have investigated the heterogeneity of the Lp(a) protein in whole plasma and in fractions prepared by density gradient ultracentrifugation, using the Western blot method. This confirmed the remarkable size heterogeneity of the Lp(a) glycoprotein and moreover demonstrated that electrophoretic Lp(a) glycoprotein phenotypes are inherited and are associated with Lp(a) lipoprotein concentrations in plasma.
Methods
Plasma samples were collected in citrate from all unrelated volunteers (n = 247) attending the Plasmadienst Tirol GmbH in Innsbruck for plasmapheresis for a period of 2 Lp(a)-lipoprotein andLp(a)-protein isolation. The purification ofLp(a) was performed using density gradient ultracentrifugation of serum or plasma according to Redgrave et al. (20) with minor modifications (21) . The distribution of Lp(a) lipoprotein in the gradient fractions was determined by electroimmunodiffusion. The Lp(a)-positive fractions from the density gradient were combined and 3 ml of the solution of d -1.06 g/ml as determined by refractometry in a parallel gradient run without sample, were layered below 2 ml density solution of d 1.019 g/ml and 3 ml density solution of 1.035 g/ml. Below the Lp(a) fraction 4 ml of density solution of d 1. 112 g/ml were layered. Centrifugation was performed in a SW 41-Rotor (Beckman) for 24 h at 40C and 40,000 rpm. Fractions of 0.5 ml were collected from below from the continuous gradient that had formed during centrifugation. The Lp(a) lipoprotein was localized in the gradient fractions by electroimmunodiffiusion using antiLp(a) serum. Purity of the Lp(a) lipoprotein was checked by PAGE (12) and by Ouchterlony double diffusion using anti-apo A-I and anti-Apo E antibodies.
In experiments designed to dissociate the Lp(a) lipoprotein, the isolated lipoprotein was incubated in the presence of 0.5 mM dithioerythritol (DTE) for 2 h at 37°C and centrifuged under the conditions described by Redgrave et al. (20) but using 3 ml of Lp(a) fraction instead of density solution 1.063 g/ml and 4 ml of density solution 1.21 g/ml instead of serum adjusted to 1.21 g/ml.
Cholesterol, apolipoprotein B, and the Lp(a) antigen were measured in the fractions. Purity of the Lp(a) protein was checked by SDS-PAGE (see Results).
Analytical and immunochemical methods. Cholesterol was measured with a commercial test kit (Boehringer Mannheim GmbH) and apolipoprotein B was determined by rocket immunoelectrophoresis. Lp(a) lipoprotein concentrations were determined by electroimmunodiffusion essentially as described by Krempler et al. (22) using polyclonal rabbit anti-Lp(a) and a purified human Lp(a) lipoprotein reference standard (Immuno AG, Vienna, Austria) prepared and calibrated essentially as described by Krempler et al. (22) . Purified Lp(a) preparations from different phenotypes (F, S1, S3) with identical protein concentrations (Lowry determination) and apo B concentration (Laurell electrophoresis) yielded identical Lp(a) lipoprotein concentrations in this assay. Antisera were produced in rabbits using LDL and Lp(a) lipoprotein as antigens following the immunization procedure described by Berg (1) . Antibodies were tested for specificity by reaction with human serum, isolated LDL, and Lp(a) lipoprotein in double diffusion experiments and by the Clark-Freeman technique as described (23). Antibodies produced against LDL exhibited only one precipitation line and reacted with apo B-100 in immunoblot experiments (anti-apo B). The antiserum against Lp(a) lipoprotein exhibited two precipitation lines, one of which showed complete identity with LDL and the other with Lp(a) but not LDL. The anti-Lp(a) serum was made specific by absorption with purified LDL and the y-Globuline (27) using the Transblot cell (Bio-Rad Laboratories). Antigens were localized on the nitrocellulose using a double-antibody procedure involving rabbit anti-Lp(a) y-globulins or anti-apo B antiserum as a first antibody and '25J-labeled anti-rabbit IgG (100,000 cpm/ ml) or gold-labeled IgG (E520 = 0.4) as the second antibody. Radioactive labeled protein bands were visualized by exposure to an X-Omat XAR5 X-ray film (Eastman Kodak Co., Rochester, NY) using a reflector Cronex Quanta IIF (DuPont Co., Wilmington, DE). The gold-labeled bands could be judged immediately or if further enhancement was needed a physical developer consisting of silver lactate and hydroquinone was employed (28) . Molecular weight determination was done in the SDS-PAGE Systeme ofNeville (26) . The high molecular weight standard from Pharmacia Fine Chemicals and apo B-100 (mol wt 500,000) were used as calibration standards. Enzymatic digestion of Lp(a) glycoprotein with neuraminidase was done according to instruction of the purchasing company. (Fig. 4) . Plasma or serum samples taken at different occasions from the same individuals always yielded identical patterns in a given subject. Hence proteases liberated during blood clotting do not affect the patterns. Moreover when plasma samples were recollected from 18 subjects under conditions minimizing proteolysis (19) , each individual exhibited essentially the same Lp(a) protein pattern as determined in the original sample. This individual constancy and high reproducability of Lp(a) glycoprotein patterns make it unlikely that the major Lp(a) protein species are proteolytic fragments. We conclude that different individuals may have Lp(a) glycoprotein species of different primary structure or different degrees ofposttranslational modification in plasma. According to their relative mobilities compared with apo B-I00, Lp(a) glycoprotein patterns were categorized into phenotypes F (faster than apo B-I00), B (similar to B-100), S1, S2, S3, and S4 (slower to different degrees than apo B-I00), and into the respective double-band phenotypes (Fig. 3) . The frequencies of these phenotypes in the plasma donors with a detectable Lp(a) band upon immunoblotting are given in Table I Dissociation ofLp(a) glycoprotein from apo B-100 lipoprotein. Lp(a) lipoprotein was isolated by density gradient ultracentrifugation. The isolated lipoprotein (2 mg protein/12 ml) was incubated with 0.5 mM DTE at 250C for 2 h and subjected to density gradient ultracentrifugation (Fig. 5) . A second aliquot ofLp(a) lipoprotein was incubated and centrifuged in the absence of DTE and served as control. Analysis ofdensity gradient fractions revealed that the DTE-treated lipoprotein had dissociated into two components, one with the density and electrophoretic mobility of LDL that contained exclusively apo B-100 and all cholesterol, and another that occurred in the bottom fractions of the gradient and contained Lp(a) glycoprotein but neither apo B-100 nor cholesterol (Figs. 5 and 6 ). The isolated Lp(a) glycoprotein had the same electrophoretic pattern as the authentic material in total plasma (Fig. 6 ).
To determine whether the differences in electrophoretic mobility of Lp(a) bands are due to differences in the sialic acid content of the sialic acid-rich protein (10), we incubated the isolated glycoproteins from subjects with phenotypes F, B, SI/ S2, and S3/S4 with neuraminidase. Lp(a) glycoprotein treated with neuraminidase had a lower apparent molecular weight by -50,000 D than the untreated protein (shown for phenotypes F and S /S2 in Fig. 7) . In Lp(a) glycoprotein preparations with a double-band phenotype both bands were shifted to a lower molecular weight range. But most importantly, the differences between the phenotypes were not abolished by treatment with neuraminidase (Fig. 7) . Hence it seems unlikely that the differences between Lp(a) phenotypes reside in the sialic acid moiety of the glycoprotein.
Association between Lp(a) phenotypes and Lp(a) lipoprotein concentration. Analysis of Lp(a) lipoprotein concentrations in healthy individuals with different single-band phenotypes suggested an association of Lp(a) glycoprotein phenotype with Lp(a) lipoprotein concentrations in plasma (Table II) . However for each phenotype the Lp(a) values measured covered a wide range. Lp(a) concentrations at the lower end ofthe total range are common whereas those at the upper end are rare, giving rise to an asymmetric, nonnormal distribution (Fig. 1) Table II ).
Family studies: results and interpretation. Pedigrees of the three families studied are shown in Fig. 8 and a respective immunoblot in Fig. 9 . The family material is still limited and contains only a few of the many possible mating types. Nevertheless the data obtained are highly indicative of a genetic transmission of Lp(a) glycoprotein phenotypes. The following relevant observations were made: (a) No Lp(a) glycoprotein species occurred in offspring that were not present in one of the parents. (b) Lp(a) species that are rare in the population (e.g., B-phenotypes; see Table I) in keeping with the population data where a high frequency of individuals present with a "null phenotype." Hence Lp(a)0 has to be considered the most fiequent allele in our population. Because the definition of a "null phenotype" depends at least in part on the sensitivity ofour assay we use the term "operational null allele" to account for this fact. Therefore individuals with a "null phenotype" may well express Lp(a) glycoprotein species even though under the detection limit of our immunoblot procedure. 
Discussion
Previous studies on the protein moiety of the Lp(a) lipoprotein have shown that it contains two major protein components, apo B-l00 and the Lp(a) glycoprotein linked by disulfide bridge formation in the intact particle (12, 13). Here we show that reductive cleavage ofdisulfide bonds in isolated Lp(a) lipoprotein by DTE . 8 ). After SDS-PAGE (6.6% gel) and electroblotting to nitrocellulose Lp(a) glycoprotein was demonstrated by incubation with rabbit anti-Lp(a) antibodies followed by gold-labeled anti-rabbit IgG. C denotes a reference plasma, and F and M the father and mother, respectively. Immunoblots from children 1-9 (same order as in pedigree) are shown. (Table I ). The most common Lp(a) species observed in the plasma donors were the S2 and S3 forms. However it should be noted that these frequencies were determined in a truncated distribution. 49% of sera did not exhibit visible Lp(a) bands upon Western blotting. Harvie and Schultz (2) have claimed that there are no true Lp(a)-negative sera. We do not know which Lp(a) species are present in those samples where Lp(a) concentrations are under the detection limit of our immunoblot method but where Lp(a) antigen was detected by electroimmunodiffusion. Our observation that Lp(a) glycoprotein forms are associated with Lp(a) concentrations indicates that the frequencies of the different Lp(a) species may be different among the negative samples in our assay. Attempts to concentrate Lp(a) from "negative" plasma samples by ultracentrifugation have failed so far. Hence, the frequencies that we have determined may not be identical to those in the total population. With our present methods, however, we can not test this hypothesis.
Another possible source of error is that a minor Lp(a) component in plasma with a major Lp(a) species might be present that is not detected due to its low concentration. This may result in an overestimation ofsingle-band phenotypes and those Lp(a) species associated with high Lp(a) concentrations. We therefore envisage our frequency determinations as first approximations.
The fact that no individual had more than two major Lp(a) species in plasma suggested to us that these phenotypes may be genetically controlled The structural differences between Lp(a) glycoprotein species are presently unknown. The differences in apparent molecular weight between Lp(a) species are enormous, -100,000 D. It seems unlikely that these differences truly reflect differences in molecular mass of Lp(a) species. It is known that glycoproteins may exhibit anomalous mobility upon SDS-PAGE (33) and that differences in carbohydrate moiety, especially in sialic acid content, may result in differences in apparent molecular weight of glycoproteins far exceeding those expected from actual differences in molecular mass between differently glycosilated proteins.
The Lp(a) lipoprotein is rich in carbohydrate, containing about six times more sialic acid than LDL (10) . This is mainly or exclusively due to the presence of the Lp(a) glycoprotein in the lipoprotein complex. Treatment of Lp(a) glycoprotein with neuraminidase expectedly reduced the apparent molecular weight ofthe protein by 50,000 D. However it did not abolish differences between the phenotypes. Therefore it seems unlikely that the different Lp(a) species result from differences in sialylation. Also the results from our family study are difficult to interpret assuming that differences between Lp(a) species are primarily due to differences in posttranslational modifications, e.g., glycosilation. However differences in the primary structure of the Lp(a) protein might secondarily effect glycosilation, thus explaining the unusual large apparent differences between Lp(a) species. A detailed analysis of the carbohydrate structures of Lp(a) species is necessary to clarify this point. The Lp(a) system is unique in that the concentration of a complex composed of a lipoprotein resembling normal low-density lipoproteins and of a high-molecular weight glycoprotein is under strong genetic control, probably from a major gene locus. The elucidation of the structural differences between Lp(a) species and studies on their synthesis and secretion in cell culture may help us understand the qualitative basis underlying the quantitative Lp(a) lipoprotein trait. Such studies are presently underway in our laboratory.
